Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.5K Buy
15,241
+1,298
+9% +$8.61K ﹤0.01% 1617
2026
Q1
$72.2K Buy
13,943
+217
+2% +$1.36K ﹤0.01% 1557
2025
Q4
$102K Sell
13,726
-92
-0.7% -$891 ﹤0.01% 1512
2025
Q3
$138K Sell
13,818
-1,601
-10% -$17.7K ﹤0.01% 1494
2025
Q2
$140K Sell
15,419
-1,456
-9% -$9.49K ﹤0.01% 1435
2025
Q1
$108K Buy
16,875
+1,531
+10% +$13.6K ﹤0.01% 1367
2024
Q4
$146K Sell
15,344
-171
-1% -$1.5K ﹤0.01% 1477
2024
Q3
$116K Sell
15,515
-246
-2% -$2.56K ﹤0.01% 1518
2024
Q2
$209K Buy
15,761
+345
+2% +$2.88K ﹤0.01% 1318
2024
Q1
$108K Buy
15,416
+22
+0.1% +$191 ﹤0.01% 643
2023
Q4
$169K Buy
15,394
+2,285
+17% +$22.4K ﹤0.01% 594
2023
Q3
$144K Hold
13,109
0.01% 452
2023
Q2
$207K Hold
13,109
0.01% 442
2023
Q1
$171K Buy
+13,109
New +$108K 0.01% 464

Other funds holding ENVX

Choreo LLC's ENVX Position: Q2 2026 in Review

Choreo LLC increased its Enovix (ENVX) stake by 9.3% in Q2 2026, buying an estimated $8.61K and bringing the position to 15,241 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Choreo LLC first reported a position in ENVX in Q1 2023 and has held it in 14 quarters since. The position peaked at $209K in Q2 2024. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Choreo LLC held 15,241 shares of Enovix worth $92.5K as of Q2 2026.
  • Choreo LLC bought 1,298 Enovix shares in Q2 2026, an estimated $8.61K.
  • Enovix made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1617 holding.
  • Choreo LLC first reported a position in Enovix in Q1 2023 and has held it in 14 quarters since.
  • Choreo LLC's Enovix position peaked at $209K in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.